Clinical Trial Update: Idylla IFV-RSV Panel Clinical Testing

View source ↗

Summary

Clinical trial NCT02786381 assessing the Idylla IFV-RSV Panel for detecting influenza and RSV completed testing with Janssen as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection
• Respiratory Tract Infection

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Respiratory Tract Infections, Influenza, Human | Status: COMPLETED